Welch Allyn® Announces New Partnership with Sensitron, Inc. in EMEA -- MEDICA - World Forum for Medicine


Welch Allyn GmbH & Co. KG

Welch Allyn® Announces New Partnership with Sensitron, Inc. in EMEA

DUSSELDORF, GERMANY – November 14, 2007-- Welch Allyn, a leading global manufacturer of Vital Signs Monitoring and Spot Checking solutions, announced today that it had formed a new partnership with Sensitron Inc., a leader in wireless patient monitoring, and its exclusive distributors in Europe, U.K. and the Middle East.
This agreement will provide a solution for ensuring that key Vital Signs data are captured with Sensitron’s careTrends® and automatically sent to a dedicated server and to an electronic medical record (EMR) when available. This solution helps to reduce transcription errors as well as time lag between the capture and posting of data.. By providing nurses and clinicians with this technology, an enhanced standard of clinical care is achieved, as well as delivering both time and budget savings.
This partnership will help clinicians meet their qualitative and quantitative objectives--giving them the right information at the right time, and reducing medical errors. Together, Welch Allyn and Sensitron will ensure that data captured from the vital signs equipment will be free of transcription errors.
Welch Allyn’s extensive range of traditional Vital Signs Monitors and Spot checkers can either be wirelessly-enabled or hard-wired by Sensitron’s careTrends®.

- more -
P. 2 – November 14, 2007
Welch Allyn Announces Partnership with Sensitron

“We believe that our partnership with Sensitron will provide the best of both worlds, data capture and data management, offering significant benefit to the patients, nurses and clinicians, “said Pascal Gand, vice president, International Marketing at Welch Allyn. “This is particularly exciting in this Vital Signs domain, where very few connected solutions exist today.”
“We are very pleased by this agreement,” said Garry Stephen, cofounder and CEO of Sensitron Europe. “It will provide users of Welch Allyn vital sign monitors with immediate and reliable data for quicker and better-informed medical decisions, while allowing medical staff to dedicate more time to their patients”

About Welch Allyn (http://www.welchallyn.com)
Founded in 1915 and headquartered in Skaneateles Falls, New York (USA), Welch Allyn is a leading global manufacturer of medical diagnostic equipment and a complete range of digital and connected solutions. With over 2,300 employees working in 17 different countries, Welch Allyn specializes in helping doctors, nurses, and other frontline practitioners across the globe provide the best patient care by developing innovative products, breakthrough technologies, and cutting edge solutions that help them see more patients, detect more conditions, and improve more lives.

About Sensitron, Inc. (http://www.sensitron.net)
Sensitron, Inc., based in San Mateo, Calif., is an international wireless healthcare innovations company that has developed *careTrends® for the med-surg units and Critical careTrends™ for the critical/intensive care units--both of which communicate vital signs and other data from wirelessly-enabled, legacy point-of-care medical devices at the patient bedside. Sensitron, Inc. was founded in 1997, is a privately-held company and is expanding internationally via channel partners.
*careTrends is Registered to Sensitron, Inc. and Critical careTrends is a Trademark of Sensitron, Inc.